ARS PharmaceuticalsSPRY
那斯達克 · USD
5.51
-0.88
(-13.71%)
收盤 08/21 03:59 (UTC+8)
盤後
5.51
5.51
(-0.09%)
08/21 03:59 (UTC+8)
ARS PharmaceuticalsSPRY
5.51
-0.88
(-13.71%)
財務數據
損益表
- -
- 0.01
- 0.02
- 0.87
- 0.08
- 0.16
- 0.33
- 0.28
- 0.23
- 0.34
- -
- -
- 313.60
- 4086.70
- -90.79
- 97.13
- 106.79
- -13.58
- -19.25
- 48.40
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 33,658 | 22,681 | 28,087 | 32,501 | 15,717 | 7,973 | 86,581 | 2,068 | 500 | - |
營業成本 | 12,846 | 6,286 | 6,154 | 8,191 | 4,984 | 1,094 | 865 | 112 | - | - |
營業毛利 | 20,812 | 16,395 | 21,933 | 24,310 | 10,733 | 6,879 | 85,716 | 1,956 | 500 | - |
營業費用 | 82,277 | 76,540 | 63,398 | 77,502 | 58,347 | 44,056 | 38,519 | 23,704 | 15,840 | - |
研發費用 | 4,698 | 4,336 | 3,443 | 2,751 | 4,035 | 2,952 | 3,027 | 4,423 | 6,896 | 5,234 |
推銷及管理費用 | 77,579 | 72,204 | 59,955 | 74,751 | 54,312 | 41,104 | 35,492 | 19,281 | 8,944 | 7,958 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -61,465 | -60,145 | -41,465 | -53,192 | -47,614 | -37,177 | 47,197 | -21,748 | -15,340 | -13,192 |
其他收入及費用 | 1,605 | 1,968 | 2,660 | 2,041 | 2,731 | 3,237 | 3,025 | 2,620 | 2,824 | 2,900 |
利息費用 | 2,479 | 2,441 | 2,599 | - | - | - | - | - | - | - |
稅前純益 | -62,339 | -60,618 | -41,404 | -51,151 | -44,883 | -33,940 | 50,222 | -19,128 | -12,516 | -10,292 |
所得稅 | - | - | -80 | - | - | - | 288 | - | - | - |
稅後純益 | -62,339 | -60,618 | -41,324 | -51,151 | -44,883 | -33,940 | 49,934 | -19,128 | -12,516 | -10,292 |
基本每股稅後盈餘(元) | -0.63 | -0.61 | -0.41 | -0.52 | -0.46 | -0.35 | - | -0.20 | -0.13 | -0.11 |
稀釋每股稅後盈餘(元) | -0.63 | -0.61 | -0.42 | -0.52 | -0.45 | -0.35 | 0.51 | -0.19 | -0.13 | -0.11 |
基本平均股數(千股) | 99312.00 | 99296.00 | 99037.00 | 98807.00 | 98361.00 | 98060.00 | - | 97032.00 | 96827.00 | 96486.00 |
稀釋平均股數(千股) | 99312.00 | 99296.00 | 99037.00 | 98807.00 | 98361.00 | 98060.00 | - | 97032.00 | 96827.00 | 96486.00 |
還原基本每股稅後盈餘(元) | -0.63 | -0.61 | -0.41 | -0.52 | -0.46 | -0.35 | - | -0.20 | -0.13 | -0.11 |
還原稀釋每股稅後盈餘(元) | -0.63 | -0.61 | -0.42 | -0.52 | -0.45 | -0.35 | 0.51 | -0.19 | -0.13 | -0.11 |
還原基本平均股數(千股) | 99,312 | 99,296 | 99,037 | 98,807 | 98,361 | 98,060 | - | 97,032 | 96,827 | 96,486 |
還原稀釋平均股數(千股) | 99,312 | 99,296 | 99,037 | 98,807 | 98,361 | 98,060 | - | 97,032 | 96,827 | 96,486 |
EBITDA(千元) | -60,094 | -58,770 | -39,391 | -51,852 | -46,071 | -35,621 | 48,707 | -20,933 | -14,402 | -12,261 |